Signal2026-05-13
ClinicalTrials.gov

[NA] Safety and Efficacy of Finerenone in Metabolic Dysfunction Associated Steatotic Liver Disease(MASLD/NAFLD) Related Cirrhosis Patients With Ascites in Prevention of Chronic Kidney Disease.

Part of

Predictive Modeling Of Chronic Liver And Metabolic Diseases